Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMI5UEB)

Drug Name

Unacylated ghrelin Drug Info

Synonyms

AZP-01; Diabetes therapeutic peptide, Theratechnologies; TH-0332; Un-octanoylated ghrelin; Unacylated ghrelin (diabetes); Ghrelin inhibitor peptides (diabetes), Theratechnologies; UAG (diabetes), Alize Pharma; Unacylated ghrelin (diabetes), Alize Pharma; Unacylated ghrelin (diabetes), Theratechnologies; Un-octanoylated ghrelin (diabetes), Alize Pharma; Unacylated ghrelin (diabetes), Alize Pharma/Eli Lilly

Indication

Disease Entry	ICD 11	Status	REF
Type-1 diabetes	5A10	Phase 1	[1]

Cross-matching ID

TTD Drug ID: DMI5UEB

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ghrelin (GHRL)	TT1OCL0	GHRL_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

References

1	Alize Pharma announces positive results for AZP-531, its unacylated ghrelin analog, from two Phase I clinical trials in healthy volunteers and obese subjects. Lyon, France, December 10, 2014.
2	Alize Pharma signs research collaboration and license option agreement with Lilly. Lyon, France, January 25, 2010.